Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10043580

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10022771

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10010219

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 9923617

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Medicines Containing The Active Ingredient Bosutinib Atc L01Ea04

Deadline: 30 Sep 2026

Germany

Ref. No.: 9904575

EMD:Ref Document

Bid Value: Ref Document

198 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 9899663

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Open Ended Justice Involved Supportive Housing Jish

Deadline: 29 Dec 2034

United States

Ref. No.: 9899114

EMD:Ref Document

Bid Value: Ref Document

3210 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 9890960

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Active Ingredient Bosutinib Atc Code L01Ea04

Deadline: 30 Nov 2026

Germany

Ref. No.: 9807398

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Open House Drug Discount Agreements Vildagliptin Atc A10Bh02

Deadline: 05 Oct 2026

Germany

Ref. No.: 9732815

EMD:Ref Document

Bid Value: Ref Document

203 Days Left

Open House Drug Discount Agreements Bosutinib Atc L01Ea04

Deadline: 05 Oct 2026

Germany

Ref. No.: 9728494

EMD:Ref Document

Bid Value: Ref Document

203 Days Left

Open House Drug Discount Agreements Rituximab Atc L01Fa01

Deadline: 05 Oct 2026

Germany

Ref. No.: 9723229

EMD:Ref Document

Bid Value: Ref Document

203 Days Left

Open House Drug Discount Agreements Trastuzumab Atc L01Fd01

Deadline: 05 Oct 2026

Germany

Ref. No.: 9723211

EMD:Ref Document

Bid Value: Ref Document

203 Days Left

Open House Drug Discount Agreements Melatonin Excluding Dosage Form 2 Mg Sustained Release Tablets Atc N05Ch01

Deadline: 05 Oct 2026

Germany

Ref. No.: 9719337

EMD:Ref Document

Bid Value: Ref Document

203 Days Left

Open House Drug Discount Agreements Chlorthalidone Atc C03Ba04

Deadline: 05 Oct 2026

Germany

Ref. No.: 9714773

EMD:Ref Document

Bid Value: Ref Document

203 Days Left

Discover Tenders by Laboratory Hygienic Or Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Laboratory Hygienic Or Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!